Neutrophil count on admission predicts major in-hospital events in patients with a non-ST-segment elevation acute coronary syndrome

Clinical Cardiology

Volumn 32, Issue 10, 2009, Pages 561-568

  Karabinos, Ilias ^a   Koulouris, Spyridon ^b   Kranidis, Athanasios ^b   Pastromas, Socrates ^b   Exadaktylos, Nikolaos ^c   Kalofoutis, Anastasios ^d  

^a Athens Euroclinic   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c SOTIRIA GENERAL HOSPITAL   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; AGED; ARTICLE; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INCIDENCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PREDICTION; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; RISK FACTOR; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEUTROPHILS; ODDS RATIO; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TREATMENT OUTCOME; TROPONIN I;

EID: 70849135369     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20624     Document Type: Article

References (30)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279:1477-1482. (Pubitemid 28228207)
3. Ernst E, Hammerschmidt DE, Bagge U, et al. Leukocytes and the risk of ischemic diseases. JAMA. 1987;257:2318-2324.
4. Sabatine MS, Morrow DA, Cannon CP, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol. 2002;40:1761-1768.
5. Mehta J, Dinerman J, Mehta P, et al. Neutrophil function in ischemic heart disease. Circulation. 1989;79:549-556. (Pubitemid 19087705)
6. Dinerman JL, Mehta JL, Saldeen TG, et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol. 1990;15:1559-1563. (Pubitemid 20174317)
7. Biasucci LM, Donofrio G, Liuzzo G, et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol. 1996;27:611-616. (Pubitemid 26080385)
8. Antman EM, Papadaki OA, Manousakis SJ, et al. The TIMI risk score for unstable angina/non ST segment elevation myocardial infarction: a method for prognostication and therapeutic decision making. JAMA. 2000;284:835.
9. Yan A, Yan R, Tan M, et al. Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better. Eur Heart J. 2007;28:1072-1078. (Pubitemid 47343862)
10. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327:146-150.
11. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl JMed. 1996;335:1342-1349. (Pubitemid 26360452)
12. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-369. (Pubitemid 36158034)
13. Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med. 2000;343:1139-1147. (Pubitemid 30781984)
14. Biasucci L, Liuzzo G, Grillo R, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation. 1999;99:855-860. (Pubitemid 29094296)
15. Zalokar JB, Richard JL, Claude JR. Leukocyte count, smoking, and myocardial infarction. N Engl JMed. 1981;304:465-468. (Pubitemid 11179004)
16. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease: insights from the Framingham Study. JAMA. 1992;267:1253-1256.
17. Barron HV, Harr SD, Radford MJ, et al. The association between white blood cell count and acute myocardial infarction mortality in patients ≥65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol. 2001;38:1654-1661.
18. Mueller C, Neumann FJ, Perruchoud AP, et al. White blood cell count and long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularization. Heart. 2003;89:389-392. (Pubitemid 36379410)
19. Haines AP, Howarth D, North WR, et al. Haemostatic variables and the outcome of myocardial infarction. Thromb Haemost. 1983;50:800-803. (Pubitemid 14218213)
20. Furman MI, Becker RC, Yarzebski J, et al. Effect of elevated leukocyte count on in-hospitalmortality following acute myocardial infarction. Am J Cardiol. 1996;78:945-948. (Pubitemid 126658660)
21. Wong CK, French JK, Gao W, et al. Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of thrombolysis in myocardial infarction-3 flow after streptokinase. Am Heart J. 2003;145:95-102. (Pubitemid 36034503)
22. Lucchesi BR, Werns SW, Fantone JC. The role of the neutrophil and free radicals in ischemic myocardial injury. J Mol Cell Cardiol. 1989;21:1241-1251. (Pubitemid 20046099)
23. Mehta JL, Nichols WW, Mehta P. Neutrophils as potential participants in acutemyocardial ischemia: relevance to reperfusion. J Am Coll Cardiol. 1988;11:1309-1316. (Pubitemid 18143526)
24. Arai M, Lefer DJ, So T, et al. An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion. J Am Coll Cardiol. 1996;27:1278-1285. (Pubitemid 26119613)
25. Palazzo AJ, Jones SP, Girod WG, et al. Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice. Am J Physiol. 1998;275:H2300-2307.
26. Bauersachs RM, Moessmer G, Koch C, et al. Flow resistance of individual neutrophils in coronary artery disease: decreased pore transit times in acute myocardial infarction. Heart. 1997;77:18-23. (Pubitemid 27076909)
27. Harlan JM, Killen PD, Harker LA, et al. Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest. 1981;68:1394-1403.
28. Ludwig PW, Hunninghake DB, Hoidal JR. Increased leucocyte oxidative metabolism in hyperlipoproteinaemia. Lancet. 1982;2:348-350.
29. Connelly JC, Skidgel RA, Schulz WW, et al. Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide. Proc Natl Acad Sci USA. 1985;82:8737-8741.
30. Takahiko N, Makiko U, Kazuo H, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002;106:2894-2900.